DocGo Inc.

NASDAQ:DCGO

3.53 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 164.95192.088199.246186.553125.487113.003108.785104.32109.519117.892121.32485.83962.18649.68931.2426.93722.53713.377
Cost of Revenue 113.274128.992132.56131.50283.61881.22666.37671.25570.17677.98871.89160.02641.02335.86120.79418.26313.9569.731
Gross Profit 51.67563.09666.68655.05141.86931.77642.40933.06539.34339.90449.43325.81321.16313.82810.4478.6738.5813.646
Gross Profit Ratio 0.3130.3280.3350.2950.3340.2810.390.3170.3590.3380.4070.3010.340.2780.3340.3220.3810.273
Reseach & Development Expenses 2.3692.3893.1853.2352.5741.8641.7221.3731.1481.1421.3390.8550.6650.5690.570.3090.1190.064
General & Administrative Expenses 38.76544.49547.00937.16633.20232.85934.8924.38727.69925.20928.91520.42517.15312.69212.559.3648.7877.907
Selling & Marketing Expenses 0.3920.3370.2041.6060.6850.3072.4060.09111.2581.7290.9941.1890.8430.3230.190.0370.193
SG&A 39.15744.83247.21238.77133.88733.16637.29624.47828.69926.46730.64321.4218.34213.53512.8739.5538.8258.272
Other Expenses 0.3160.240.9690.048-0.920.2153.3123.0152.0382.2011.9972.021.8971.5981.4421.371.350
Operating Expenses 41.52647.2255.01346.34340.29338.67942.32928.86631.88529.80933.9824.29420.90415.70214.88511.23210.2949.699
Operating Income 10.14915.87511.6748.7081.576-6.9033.0765.9884.4310.09515.4531.5190.259-1.874-4.438-2.559-1.713-6.035
Operating Income Ratio 0.0620.0830.0590.0470.013-0.0610.0280.0570.040.0860.1270.0180.004-0.038-0.142-0.095-0.076-0.451
Total Other Income Expenses Net -0.582-0.1530.5160.103-1.1090.045-5.052-3.127.648-0.2825.0860.143-0.028-0.1150.339-0.0190.028-0
Income Before Tax 9.56715.72212.1969.1570.989-6.049-1.9772.86812.0789.81320.2771.4060.101-1.989-4.229-2.652-1.703-6.036
Income Before Tax Ratio 0.0580.0820.0610.0490.008-0.054-0.0180.0270.110.0830.1670.0160.002-0.04-0.135-0.098-0.076-0.451
Income Tax Expense 3.7095.1194.2034.527-0.355-2.13-9.1250.4020.3220.440.0020.605-0.0010.010.1640.0040.0110.001
Net Income 6.5311.2277.574.765-2.011-3.4668.0652.46612.73610.6323.5613.508-1.646-1.678-4.492-2.398-2.047-6.037
Net Income Ratio 0.040.0580.0380.026-0.016-0.0310.0740.0240.1160.090.1940.041-0.026-0.034-0.144-0.089-0.091-0.451
EPS 0.0640.110.0730.046-0.019-0.0340.0790.0240.110.0920.20.035-0.016-0.017-0.045-0.024-0.02-66.71
EPS Diluted 0.0610.10.0730.045-0.019-0.0340.0790.0230.110.0920.20.035-0.016-0.017-0.045-0.024-0.02-66.71
EBITDA 14.35120.05816.712.8945.506-3.1986.3889.0036.46812.35412.3043.3962.184-0.276-3.335-1.171-0.39-4.69
EBITDA Ratio 0.0870.1040.0840.0690.044-0.0280.0590.0860.0590.1050.1010.040.035-0.006-0.107-0.043-0.017-0.351